Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Slifstein

Showing results (21-30 of 131) with videos related to

Pageof 14
Sort By:
Synapse (New York, N.Y.)|August 10, 2004
Effect of amphetamine on [(18)F]fallypride in vivo binding to D(2) receptors in striatal and extrastriatal regions of the primate brain: Single bolus and bolus plus constant infusion studiesMark Slifstein, Raj Narendran, Dah-Ren Hwang, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|August 24, 2023
An improved synthesis of [<sup>18</sup> F]VAT and its precursorBao Hu, Hari K Akula, Doyoung Noh, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 22, 2007
[11C]NNC 112 selectivity for dopamine D1 and serotonin 5-HT(2A) receptors: a PET study in healthy human subjectsMark Slifstein, Lawrence S Kegeles, Robyn Gonzales, et al.
Synapse (New York, N.Y.)|November 23, 2006
Amphetamine-induced dopamine release: duration of action as assessed with the D2/3 receptor agonist radiotracer (-)-N-[(11)C]propyl-norapomorphine ([11C]NPA) in an anesthetized nonhuman primateRajesh Narendran, Mark Slifstein, Dah-Ren Hwang, et al.
Psychopharmacology|March 17, 2004
In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primatesMark Slifstein, Dah-Ren Hwang, Yiyun Huang, et al.
Neuroimage|July 26, 2011
Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tonePeter S Talbot, Mark Slifstein, Dah-Ren Hwang, et al.
Biological Psychiatry|August 23, 2011
Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL 100907Helen Blair Simpson, Mark Slifstein, James Bender, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 2, 2012
Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopyHelen B Simpson, Dikoma C Shungu, James Bender, et al.
Biological Psychiatry|February 4, 2011
Imaging changes in glutamate transmission in vivo with the metabotropic glutamate receptor 5 tracer [11C] ABP688 and N-acetylcysteine challengeNobumi Miyake, Mette Skinbjerg, Balu Easwaramoorthy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2006
Biodistribution and radiation dosimetry of the dopamine D2 ligand 11C-raclopride determined from human whole-body PETMark Slifstein, Dah-Ren Hwang, Diana Martinez, et al.
Pageof 14

Showing results (21-30 of 131) with videos related to

Sort By:
Pageof 14
Synapse (New York, N.Y.)|August 10, 2004
Effect of amphetamine on [(18)F]fallypride in vivo binding to D(2) receptors in striatal and extrastriatal regions of the primate brain: Single bolus and bolus plus constant infusion studiesMark Slifstein, Raj Narendran, Dah-Ren Hwang, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|August 24, 2023
An improved synthesis of [<sup>18</sup> F]VAT and its precursorBao Hu, Hari K Akula, Doyoung Noh, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 22, 2007
[11C]NNC 112 selectivity for dopamine D1 and serotonin 5-HT(2A) receptors: a PET study in healthy human subjectsMark Slifstein, Lawrence S Kegeles, Robyn Gonzales, et al.
Synapse (New York, N.Y.)|November 23, 2006
Amphetamine-induced dopamine release: duration of action as assessed with the D2/3 receptor agonist radiotracer (-)-N-[(11)C]propyl-norapomorphine ([11C]NPA) in an anesthetized nonhuman primateRajesh Narendran, Mark Slifstein, Dah-Ren Hwang, et al.
Psychopharmacology|March 17, 2004
In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primatesMark Slifstein, Dah-Ren Hwang, Yiyun Huang, et al.
Neuroimage|July 26, 2011
Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tonePeter S Talbot, Mark Slifstein, Dah-Ren Hwang, et al.
Biological Psychiatry|August 23, 2011
Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL 100907Helen Blair Simpson, Mark Slifstein, James Bender, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 2, 2012
Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopyHelen B Simpson, Dikoma C Shungu, James Bender, et al.
Biological Psychiatry|February 4, 2011
Imaging changes in glutamate transmission in vivo with the metabotropic glutamate receptor 5 tracer [11C] ABP688 and N-acetylcysteine challengeNobumi Miyake, Mette Skinbjerg, Balu Easwaramoorthy, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2006
Biodistribution and radiation dosimetry of the dopamine D2 ligand 11C-raclopride determined from human whole-body PETMark Slifstein, Dah-Ren Hwang, Diana Martinez, et al.
Pageof 14